Molecular regulation underlying differentiation of dental pulp stem cells
牙髓干细胞分化的分子调控
基本信息
- 批准号:8812561
- 负责人:
- 金额:$ 36.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:3&apos Untranslated RegionsAdultBindingBioinformaticsBone Marrow Stem Cell TransplantationCell SeparationCell TherapyCellsCodeDentalDental PulpDevelopmentDiseaseDown-RegulationElementsEthical IssuesFluorescenceFutureGene ExpressionGene ProteinsGenesGlobal ChangeGoalsHeat shock proteinsImmune responseIn VitroInjuryLate EffectsLightMedicineMessenger RNAMethodsMicroRNAsMolecularNatural regenerationNorthern BlottingOrganPatientsPlayPolyadenylationPoriferaPropertyProteinsProteomeRattusRegenerative MedicineRegulationRegulator GenesRegulatory ElementResearchResponse ElementsReverse Transcriptase Polymerase Chain ReactionRoleSignal TransductionSmall RNASourceStem cellsTeratomaTestingTherapeuticTimeTissue EngineeringTissuesTooth structureTransfectionTranslationsTransplantationTwo-Dimensional Gel ElectrophoresisWestern Blottingadult stem celldesignembryonic stem cellexpression vectorgain of functionhuman diseaseimprovedinduced pluripotent stem cellleukemialoss of functionnovelnovel strategiesoverexpressionpreventpublic health relevancerepairedstemstem cell differentiationstemnesstissue regenerationtumorigenesistwo-dimensionalvector
项目摘要
DESCRIPTION (provided by applicant): Utilization of stem cells to repair diseased or damaged tissues/organs represents a novel approach for remedies in regenerative medicine. Although embryonic stem cells (ESC) and induced pluripotent stem cells (iPS) have been studied, there are major drawbacks and concerns in using ESC and iPS; for example, tumorigenesis and teratomas formation can occur after their transplantation. It is not clear if the
obstacles pertaining to ESC and iPS can be overcome in order to use them for therapeutics; at least there is still long way to go. In contrast, adult stem cells (AdSC) are used for treatment of
human diseases. One example is the transplantation of bone marrow stem cells to cure or improve certain disorders, such as leukemia. Such cell- based therapies usually require large numbers of stem cells. Because AdSC lose their stem cell properties (stemness) including differentiation capability when cultured in vitro, primary isolated AdSC can only be used for limited passages, and propagation of a large quantity of high-potential stem cells from primary isolation is difficult. Thus, large amounts of tissues are needed for stem cell isolation, and continuous isolation of AdSC is required for multiple treatments. However, tissues, e.g., dental tissues that can be used for AdSC isolation are often limited. Stem cells isolated from dental pulp of extracted and exfoliated teeth have been shown to be a good source of stem cells for regenerative medicine. However, like other AdSC, these dental pulp stem cells (DPSCs) also lose their differentiation potential when cultured in vitro, which hampers their applications. The long-term goal of this research is to elucidate the genes and molecules regulating differentiation capability in the DPSCs. Preliminary studies showed that heat shock protein B8 (HspB8) was downregulated in cultured DPSCs when the cells lost differentiation capability, and knockdown of HspB8 expression in the early passage DPSCs caused the cells to lose differentiation capability. Further studies suggested that microRNAs (miRNAs) are responsible for downregulation of HspB8 expression in DPSCs. The central hypothesis is that upregulated expression of certain miRNAs in late passage DPSCs downregulates HspB8 and other regulatory genes, and in turn causes DPSCs to lose differentiation capability during in vitro culture. The project Aims: (1) to identify the miRNAs whose expression is substantially increased in late passage DPSCs, designated as late-passage upregulated miRNAs (LPU-miRNAs); (2) to identify the LPU-miRNAs that downregulate HspB8 expression; i.e., HspB8-targeting miRNAs, and (3) to study the effects of LPU-miRNAs and HspB8-targeting miRNAs on DPSC differentiation and on regulating other potential genes. Accomplishment of the Aims would be significant in understanding the roles of miRNAs and HspB8 in regulating the loss of differentiation seen in the long-term cultured DPSCs and will shed light on other AdSC as well. This would facilitate the development of cutting- edge methods for maintaining the stem cell properties in culturing DPSCs and AdSC, such that a large quantity of stem cells with high-differentiation potential can be obtained from expansion of primary isolated stem cells.
描述(通过应用提供):使用干细胞修复解散或受损的组织/器官代表了再生医学中的一种新方法。尽管胚胎干细胞(ESC)和诱导的多能干细胞(IPS)已经研究了,但使用ESC和IPS存在主要的缺点和关注。例如,肿瘤发生后可能发生在移植后。目前尚不清楚是否是
可以克服与ESC和IP有关的障碍,以便将其用于治疗;至少还有很长的路要走。相反,成年干细胞(ADSC)用于治疗
人类疾病。一个例子是骨髓干细胞的移植以治愈或改善某些疾病,例如白血病。这种基于细胞的疗法通常需要大量的干细胞。由于ADSC在体外培养时会失去其干细胞特性(Stem),包括分化能力,因此只能用于有限的传递,而将大量高电位干细胞从主要分离中传播。干细胞分离需要大量组织,并且需要连续隔离ADSC来进行多种治疗。但是,例如可用于ADSC隔离的牙科组织通常受到限制。从提取的牙齿和去角质牙齿的牙髓中分离出来的干细胞已被证明是再生医学干细胞的良好来源。但是,与其他ADSC一样,这些牙髓干细胞(DPSC)在体外培养时也会失去其分化潜力,从而阻碍其应用。这项研究的长期目标是阐明基因和分子调节DPSC中的分化能力。初步研究表明,当细胞失去分化能力时,热休克蛋白B8(HSPB8)在培养的DPSC中被下调,并且在早期传递DPSC中敲低HSPB8表达会导致细胞失去分化能力。进一步的研究表明,microRNA(miRNA)负责DPSC中HSPB8表达的下调。中心假设是,在晚期DPSC中,某些miRNA的表达更新了HSPB8和其他调节基因,进而导致DPSC在体外培养过程中失去分化能力。该项目的目的是:(1)确定在晚期DPSC中表达的miRNA,被指定为上调的miRNA(LPU-MIRNA); (2)识别下调HSPB8表达的LPU-MIRNA;即,靶向Hspb8靶向miRNA,以及(3)研究LPU-MIRNA和HSPB8靶向miRNA对DPSC分化以及调节其他潜在基因的影响。实现目标对于理解miRNA和HSPB8在确定长期培养的DPSC中看到的分化损失方面的作用将是重要的,并且还将阐明其他ADSC。这将支持开发用于维持DPSC和ADSC中干细胞特性的尖端方法,从而可以通过膨胀的主要分离干细胞的扩展获得了大量具有高分化潜力的干细胞。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Expression of microRNAs targeting heat shock protein B8 during in vitro expansion of dental pulp stem cells in regulating osteogenic differentiation.
- DOI:10.1016/j.archoralbio.2019.104485
- 发表时间:2019-11
- 期刊:
- 影响因子:3
- 作者:S. Yao;Chunhong Li;Angelle M Budenski;P-A Li;A. Ramos;Steven Guo
- 通讯作者:S. Yao;Chunhong Li;Angelle M Budenski;P-A Li;A. Ramos;Steven Guo
MicroRNA biogenesis and their functions in regulating stem cell potency and differentiation.
- DOI:10.1186/s12575-016-0037-y
- 发表时间:2016
- 期刊:
- 影响因子:6.4
- 作者:Yao S
- 通讯作者:Yao S
Increased Expression of miR-7a-5p and miR-592 during Expansion of Rat Dental Pulp Stem Cells and Their Implication in Osteogenic Differentiation.
- DOI:10.1159/000519600
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Rong W;Rome C;Yao S
- 通讯作者:Yao S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shaomian Yao其他文献
Shaomian Yao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shaomian Yao', 18)}}的其他基金
Molecular basis for the loss of differentiation capability in human bone marrow stem cells during expansion
人骨髓干细胞扩增过程中分化能力丧失的分子基础
- 批准号:
10057914 - 财政年份:2020
- 资助金额:
$ 36.22万 - 项目类别:
Molecular basis for the loss of differentiation capability in human bone marrow stem cells during expansion
人骨髓干细胞扩增过程中分化能力丧失的分子基础
- 批准号:
10240719 - 财政年份:2020
- 资助金额:
$ 36.22万 - 项目类别:
Development of selection techniques for purifying stem cells from dental tissues
开发从牙组织中纯化干细胞的选择技术
- 批准号:
7588220 - 财政年份:2009
- 资助金额:
$ 36.22万 - 项目类别:
Development of selection techniques for purifying stem cells from dental tissues
开发从牙组织中纯化干细胞的选择技术
- 批准号:
7784538 - 财政年份:2009
- 资助金额:
$ 36.22万 - 项目类别:
相似海外基金
The mechanism of CELF1 upregulation and its role in the pathogenesis of Myotonic Dystrophy Type 1
CELF1上调机制及其在强直性肌营养不良1型发病机制中的作用
- 批准号:
10752274 - 财政年份:2024
- 资助金额:
$ 36.22万 - 项目类别:
Activity-Dependent Regulation of CaMKII and Synaptic Plasticity
CaMKII 和突触可塑性的活动依赖性调节
- 批准号:
10817516 - 财政年份:2023
- 资助金额:
$ 36.22万 - 项目类别:
Genetic and pharmacologic elimination of myotonia from myotonic dystrophy type 1
通过遗传和药物消除 1 型强直性肌营养不良引起的肌强直
- 批准号:
10750357 - 财政年份:2023
- 资助金额:
$ 36.22万 - 项目类别:
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
了解淋巴瘤对蛋白精氨酸甲基转移酶抑制剂的耐药机制
- 批准号:
10668754 - 财政年份:2023
- 资助金额:
$ 36.22万 - 项目类别:
Potentials of Epigenetic Molecules in Attenuating the Phenotypes of Periodontitis
表观遗传分子减轻牙周炎表型的潜力
- 批准号:
10736171 - 财政年份:2023
- 资助金额:
$ 36.22万 - 项目类别: